A
Anna A. W. van Geloven
Researcher at University of Amsterdam
Publications - 47
Citations - 2571
Anna A. W. van Geloven is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 18, co-authored 35 publications receiving 2016 citations.
Papers
More filters
Journal ArticleDOI
Laparoscopy in Combination with Fast Track Multimodal Management is the Best Perioperative Strategy in Patients Undergoing Colonic Surgery A Randomized Clinical Trial (LAFA-study)
Malaika S. Vlug,Jan Wind,Markus W. Hollmann,Dirk T. Ubbink,Huib A. Cense,Alexander Engel,Michael F. Gerhards,Bart A. van Wagensveld,Edwin S. van der Zaag,Anna A. W. van Geloven,Mirjam A. G. Sprangers,Miguel A. Cuesta,Willem A. Bemelman +12 more
TL;DR: Optimal perioperative treatment for patients requiring segmental colectomy for colon cancer is laparoscopic resection embedded in a FT program, and if open surgery is applied, it is preferentially done in FT care.
Journal ArticleDOI
Laparoscopic peritoneal lavage or sigmoidectomy for perforated diverticulitis with purulent peritonitis: a multicentre, parallel-group, randomised, open-label trial
Sandra Vennix,Gijsbert D. Musters,Irene M. Mulder,Hilko A Swank,Esther C. J. Consten,Eric Belgers,Anna A. W. van Geloven,Michael F. Gerhards,Marc J.P.M. Govaert,Wilhelmina M U van Grevenstein,Anton G M Hoofwijk,Philip M Kruyt,Simon W. Nienhuijs,Marja A. Boermeester,Jefrey Vermeulen,Susan van Dieren,Johan F. Lange,Willem A. Bemelman +17 more
TL;DR: Laroscopic lavage is not superior to sigmoidectomy for the treatment of purulent perforated diverticulitis and Hartmann's procedure, or primary anastomosis in a parallel design after diagnostic laparoscopy.
Journal ArticleDOI
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
Charlotte E. L. Klaver,Daniel D Wisselink,Cornelis J. A. Punt,Petur Snaebjornsson,Johannes Crezee,Arend G. J. Aalbers,Alexandra Brandt,A.J.A. Bremers,Jacobus W. A. Burger,Hans F. J. Fabry,Floris Ferenschild,Sebastiaan Festen,Wilhelmina M U van Grevenstein,Patrick H. J. Hemmer,Ignace H. J. T. de Hingh,Niels F. M. Kok,Gijsbert D. Musters,Lotte Schoonderwoerd,Jurriaan B. Tuynman,Anthony W. H. van de Ven,Henderik L van Westreenen,Marinus J. Wiezer,David D. E. Zimmerman,Annette A van Zweeden,Marcel G. W. Dijkgraaf,Pieter J. Tanis,Caroline S. Andeweg,Vivian P. Bastiaenen,Willem A. Bemelman,Jarmila D. W. van der Bilt,Johanne Bloemen,Frank C. den Boer,Djamila Boerma,Daan ten Bokkel Huinink,Walter J.A. Brokelman,Huib A. Cense,Esther C. J. Consten,Geert-Jan Creemers,Rogier M P H Crolla,J. W. T. Dekker,Jennifer Demelinne,Marc J. van Det,Karin K. van Diepen,Marjolein Diepeveen,Eino B. van Duyn,Esther D. van den Ende,Pauline Evers,Anna A. W. van Geloven,Erwin van der Harst,Jeroen Heemskerk,Joost T. Heikens,Daniel A. Hess,Bas Inberg,Jan Jansen,Frank W.H. Kloppenberg,Thomas J.M. Kootstra,R.T.J. Kortekaas,Maartje Los,Eva V. E. Madsen,H.C.J. van der Mijle,Linda Mol,P.A. Neijenhuis,Simon W. Nienhuijs,Loes van den Nieuwenhof,Koen C.M.J. Peeters,Sebastiaan W. Polle,Jolien Pon,Pieter Poortman,Sandra A Radema,Bert van Ramshorst,Philip R. de Reuver,Koen P. Rovers,Roderick F. Schmitz,Nina R. Sluiter,Dirkje W. Sommeijer,D. J. A. Sonneveld,T.C. van Sprundel,Sanne C. Veltkamp,Maarten Vermaas,Victor J. Verwaal,Emma C. E. Wassenaar,Johannes A. Wegdam,Johannes H. W. de Wilt,M. Westerterp,Fennie Wit,Arjen J. Witkamp,Karlijn van Woensdregt,Edwin S. van der Zaag,Mandy Zournas +88 more
TL;DR: In patients with T4 or perforated colon cancer, treatment with adjuvant HIPEC with oxaliplatin did not improve peritoneal metastasis-free survival at 18 months, and there was no difference in peritonealan metastasis free-survival in the intention-to-treat population.
Journal ArticleDOI
Perioperative strategy in colonic surgery; LAparoscopy and/or FAst track multimodal management versus standard care (LAFA trial)
Jan Wind,Jan Hofland,Benedikt Preckel,Markus W. Hollmann,Patrick M.M. Bossuyt,Dirk J. Gouma,Mark I. van Berge Henegouwen,Jan Willem Fuhring,Cornelis H. C. Dejong,Ronald M. van Dam,Miguel A. Cuesta,Astrid Noordhuis,Dick de Jong,Edith van Zalingen,Alexander Engel,T Hauwy Goei,I Erica de Stoppelaar,Willem F. van Tets,Bart A. van Wagensveld,Annemiek Swart,Maarten J L J van den Elsen,Michael F. Gerhards,Laurens Th de Wit,Muriel A M Siepel,Anna A. W. van Geloven,Jan-Willem Juttmann,Wilfred Clevers,Willem A. Bemelman +27 more
TL;DR: The randomized controlled multicenter LAFA-trial was conceived to determine whether laparoscopic surgery, fast track perioperative care or a combination of both is to be preferred over open surgery with standard care in patients having segmental colectomy for malignant disease.
Journal ArticleDOI
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial
Cyriel Y. Ponsioen,E. Joline de Groof,Emma J. Eshuis,Tjibbe J. Gardenbroek,Patrick M.M. Bossuyt,Ailsa Hart,Janindra Warusavitarne,Christianne J. Buskens,Ad A. van Bodegraven,Menno A. Brink,Esther C. J. Consten,Bart A. van Wagensveld,Marno C.M. Rijk,Rogier M P H Crolla,Casper G. Noomen,Alexander P.J. Houdijk,Rosalie C Mallant,Maarten J Boom,Willem A. Marsman,H. B. A. C. Stockmann,Bregje Mol,A Jeroen de Groof,Pieter C. F. Stokkers,Geert R. D'Haens,Willem A. Bemelman,Karlien F. Bruin,John Maring,Theo J.M. van Ditzhuijsen,Hubert A Prins,Jan van den Brande,Paul Kingma,Anna A. W. van Geloven,Nanne K. H. de Boer,Donald L. van der Peet,Jeroen M. Jansen,Michael F. Gerhards,Janneke van der Woude,Ruud Schouten,Bas Oldenburg,Richard van Hillegersberg,Rachel L. West,Guido Mannaerts,Marcel Spanier,Ernst Jan Spillenaar Bilgen,Rob J. Lieverse,Edwin S. van der Zaag,Annekatrien Depla,Arnold van de Laar,Clemens Bolwerk,Hans Brouwer,Nofel Mahmmod,Eric J. Hazebroek,Juda Vecht,Robert E G J M Pierik,Gerard Dijkstra,Sijbrand Hofker,Tessa Uiterwaal,Quirijn A. J. Eijsbouts,Liekele Oostenbrug,Meindert N. Sosef,Djuna Cahen,Sjoerd van der Werff,Andreas Marinelli,Job H.C. Peters,Huib A. Cense,Nynke Talstra,Pritesh Morar +66 more
TL;DR: In this randomised controlled, open-label trial, adults with non-stricturing, ileocaecal Crohn's disease, in whom conventional therapy has failed were randomly allocated to have resection or receive infliximab to assess how they affect health-related quality of life.